The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1577
ISSUE1577
July 29, 2019
Cyclosporine 0.09% Solution (Cequa) for Dry Eye Disease
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Cyclosporine 0.09% Solution (Cequa) for Dry Eye Disease
July 29, 2019 (Issue: 1577)
The FDA has approved cyclosporine 0.09% ophthalmic
solution (Cequa – Sun) to increase tear production
in patients with keratoconjunctivitis sicca (dry eye
disease). Restasis, a 0.05% cyclosporine emulsion,
was approved in the US in 2003 for the...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.